Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed product... InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States. Mehr anzeigen
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced PR Newswire YOKNEAM, Israel, Jan. 16, 2025 Conference call...
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback PR Newswire MIAMI, Jan. 15, 2025 Believes the Board Must...
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M PR Newswire YOKNEAM, Israel, Jan. 8...
InMode to Present at Upcoming Investor Conferences PR Newswire YOKNEAM, Israel, Nov. 6, 2024 YOKNEAM, Israel, Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of...
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first...
InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories PR Newswire IRVINE, Calif., Oct. 24, 2024...
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 PR Newswire YOKNEAM, Israel, Oct. 10, 2024 Expects Q3 Revenue Between $130.0 Million -$130.1...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.87 | 5.40708514605 | 16.09 | 16.97 | 15.73 | 848946 | 16.52356707 | CS |
| 4 | 0.01 | 0.0589970501475 | 16.95 | 17.45 | 15.43 | 871644 | 16.59230021 | CS |
| 12 | -0.73 | -4.12662521198 | 17.69 | 19.84 | 15.43 | 972821 | 17.94230884 | CS |
| 26 | -0.86 | -4.82603815937 | 17.82 | 19.84 | 14.87 | 1066028 | 17.12407156 | CS |
| 52 | -5.74 | -25.2863436123 | 22.7 | 26.8 | 14.87 | 1236963 | 18.76372552 | CS |
| 156 | -27.46 | -61.8190004502 | 44.42 | 54.68 | 14.87 | 1543829 | 28.32798751 | CS |
| 260 | -28.09 | -62.3529411765 | 45.05 | 180 | 13.14 | 1329624 | 38.90295991 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
